Join Growin Stock Community!
Back to CVS.US Analysis
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

eps-diluted-chart

CVS EPS Diluted

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

As of Q4'25 (2025-12-31), CVS reported an EPS Diluted of 2.3 USD, marking a significant rebound from the previous quarter’s negative EPS of -3.13 USD in Q3'25. The year-over-year EPS growth for Q4'25 reached 75.57%, indicating a strong recovery in earnings performance at the end of the period. From Q1'23 to Q4'25, CVS’s EPS Diluted exhibited considerable volatility, with notable declines in Q1'24 (0.88 USD) and a sharp drop to -3.13 USD in Q3'25, followed by a rapid recovery to 2.3 USD in Q4'25. The EPS Growth (YoY) trend mirrors this volatility, with significant negative growth in Q3'24 (-96%) and Q3'25 (-4571.43%), but strong positive growth in Q3'23 (167.31%) and Q4'25 (75.57%). Overall, the chart highlights periods of both sharp decline and robust recovery, reflecting an unstable earnings environment over the observed quarters.